MADELINE WATERS: Open Payments
NPI 1922486844 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,687 in 139 payments from 38 companies in 2025. Trend: 2023 $1,973 · 2024 $5,935 · 2025 $3,687
Food & beverage: $3,687
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $428 |
| Novartis Pharmaceuticals Corporation | 17 | $421 |
| Regeneron Healthcare Solutions, Inc. | 7 | $226 |
| PFIZER INC. | 11 | $217 |
| Merck Sharp & Dohme LLC | 8 | $206 |
| Janssen Biotech, Inc. | 8 | $184 |
| ABBVIE INC. | 7 | $184 |
| Celgene Corporation | 9 | $176 |
| AstraZeneca Pharmaceuticals LP | 6 | $145 |
| Incyte Corporation | 6 | $141 |
Products named: DATROWAY, LIBTAYO, Enhertu, REBLOZYL, KEYTRUDA, LUTATHERA, IBRANCE, IMBRUVICA.
Industry payments across FL — which companies pay providers there.
